Nova Leap Health Announces Record Financial Performance for 2025
HALIFAX, Nova Scotia – Nova Leap Health Corp., a prominent provider of home-based and community care services across North America, has released its financial results for the year ended December 31, 2025, marking the most successful period in the company's history.
Record-Breaking Financial Achievements
The company achieved unprecedented financial milestones throughout 2025, setting new records across all operational segments. Nova Leap reported consolidated revenues of $31.5 million for the full year, representing a substantial 22.2% increase from the $25.8 million recorded in 2024. This growth trajectory demonstrates the company's expanding market presence and operational efficiency.
Key financial highlights include:
- Record consolidated revenues across all operations
- Record consolidated gross margin performance
- Record consolidated Adjusted EBITDA of $2,046,173
- Record revenues in both Canadian and U.S. operating segments
- Record gross margins in both geographic segments
- Record Adjusted EBITDA in both Canadian and U.S. operations
Quarterly Performance Analysis
For the fourth quarter of 2025, Nova Leap reported revenues of $8,087,783, which represents a 22.8% increase compared to the same period in 2024. While this figure shows a modest 2.1% decrease from the third quarter of 2025, the year-over-year growth remains impressive.
The company's Adjusted EBITDA for Q4 2025 reached $508,500, marking a 23.1% improvement over the $412,947 reported in Q4 2024. This performance contributed to the full-year Adjusted EBITDA of $2,046,173, which represents a significant 31.0% increase from the $1,561,761 recorded in 2024.
Financial Health and Strategic Position
Nova Leap demonstrated strong financial management throughout 2025, with gross profit margin increasing to 39.7% from 38.4% in the previous year. The company maintained excellent accounts receivable collection rates at 99.5%, slightly improving upon the 99.4% rate achieved in 2024.
Operating income showed substantial growth, reaching $1,105,998 for the full year – a 28.1% increase over the $863,712 recorded in 2024. The company ended the year with cash and cash equivalents of $1,492,925 and maintained full access to an unutilized revolving credit facility of $1,094,411 (CAD$1,500,000).
Strategic financial positioning remains a cornerstone of Nova Leap's approach, with the company maintaining a leverage ratio of 1.02 times its 2025 Adjusted EBITDA. This conservative financial structure provides flexibility for future growth initiatives.
Future Growth Prospects
As of December 31, 2025, Nova Leap had access to up to $4,691,000 in available credit specifically designated for business acquisitions through its existing credit agreement. This financial capacity supports the company's long-term growth strategy focused on both organic expansion and strategic acquisitions.
Chris LeBlanc, Chief Financial Officer of Nova Leap, commented on the results: "2025 marked the strongest financial performance in Nova Leap's history, with record results across both our Canadian and U.S. operations. Importantly, this growth was achieved while maintaining a strong balance sheet with low leverage and meaningful available liquidity. Our disciplined financial management positions the Company well to continue investing in organic growth and strategic acquisitions in the future."
The company's performance reflects the growing demand for home-based and community care services across North America, with Nova Leap positioned to capitalize on this expanding market segment through its proven operational model and strategic financial management.
